In last trading session, Third Harmonic Bio Inc. (NASDAQ:THRD) saw 0.11 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $19.00 trading at -$0.76 or -3.85% at ring of the bell on the day assigns it a market valuation of $715.35M. That closing price of THRD’s stock is at a discount of -29.42% from its 52-week high price of $24.59 and is indicating a premium of 15.79% from its 52-week low price of $16.00. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.12 million shares which gives us an average trading volume of 155.75K if we extend that period to 3-months.
Third Harmonic Bio Inc. (NASDAQ:THRD) trade information
Upright in the red during last session for losing -3.85%, in the last five days THRD remained trading in the green while hitting it’s week-highest on Wednesday, 11/23/22 when the stock touched $19.00 price level, adding 7.27% to its value on the day. Third Harmonic Bio Inc.’s shares saw a change of -3.46% in year-to-date performance and have moved 4.97% in past 5-day. Third Harmonic Bio Inc. (NASDAQ:THRD) showed a performance of 3.26% in past 30-days. Number of shares sold short was 0.11 million shares which calculate 0.5 days to cover the short interests.
Third Harmonic Bio Inc. is more likely to be releasing its next quarterly report in December and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Third Harmonic Bio Inc. (NASDAQ:THRD)’s Major holders
Insiders are in possession of 11.87% of company’s total shares while institution are holding 73.43 percent of that, with stock having share float percentage of 83.32%. Investors also watch the number of corporate investors in a company very closely, which is 73.43% institutions for Third Harmonic Bio Inc. that are currently holding shares of the company.